Navigation Links
Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery
Date:7/11/2014

Scottsdale, AZ (PRWEB) July 11, 2014

Cayenne Medical, Inc., a privately held sports medicine device company specializing in the soft tissue reconstruction segment, announced the worldwide launch of the SureLock All-Suture Anchor System for surgeries involving the shoulder and extremities. The SureLock System provides strong, predictable fixation through a novel, inserter-controlled deployment method. The unique delivery eliminates manual tensioning that can lead to partial deployment, anchor pull-out, or anchor displacement (also commonly know as anchor “creep”). SureLock keeps the creep out of all-suture anchor fixation by consistently deploying the anchor beneath the cortex. The SureLock System will be on display for demonstration during the 2014 American Orthopaedic Society for Sports Medicine Annual Meeting (AOSSM), July 10-12, Seattle, Washington at booth # 313.

“Cayenne Medical has seen great clinical success with the SureLock All-Suture Anchor System since its limited market release earlier this year, and we are excited to announce a full market launch which allows us to open up domestic and international markets,” said Dave Springer, President and CEO of Cayenne Medical. “We are delighted that many surgeons have embraced the reliable technology of our innovative all-suture anchor, which builds upon our best-in-class soft tissue repair solutions for the knee, shoulder and extremities.”

The SureLock All-Suture Anchor is composed of Ultra High Molecular Weight Polyethylene (UHMWPE) suture and is available in 1.4mm (single loaded) and 2.2mm (double loaded) sizes. SureLock requires a smaller pilot hole compared to traditional anchors, minimizing bone removal and decreasing the overall anchor footprint, while still providing superior strength. The SureLock delivery system is designed to provide a consistent, reproducible technique to eliminate the inconsistency seen with other all-suture anchors on the market.

"The SureLock Anchor provides excellent stability immediately upon deployment without the worry of anchor creep commonly seen with other all-suture anchors,” states Andrew Willis, MD, of Tri-County Orthopedics, Morristown, New Jersey. “This superior product delivers the reliability and strength of a traditional suture anchor, yet has the advantages of an all-suture anchor construct. The SureLock System is the next generation of all-suture anchor fixation because it brings you the best of both worlds."

About Cayenne Medical, Inc.
Cayenne Medical designs, develops and markets technically advanced soft tissue reconstruction solutions for the knee, shoulder, and extremities. Founded in 2005, the company is leading the transformation of traditional arthroscopic procedures by applying innovative technology through minimally invasive techniques.

Cayenne Medical Product Lines
The complete sports medicine offering of knee products includes: AperFix® ,the only soft tissue multi-ligament system with rigid aperture fixation, CrossFix®, an all-suture meniscal repair device, and iFix®, for bone-tendon-bone fixation. Cayenne Medical also offers the Quattro System®, a complete line of shoulder products for rotator cuff repair, labral repair, and beyond. The company recently expanded its product portfolio to include the Mirror™ Partial Knee System, incorporating proprietary technology that uniquely tensions the ligaments to balance the knee throughout the entire range of motion.

For more information, please visit http://www.cayennemedical.com.

###
Cayenne Medical, AperFix, CrossFix, iFix and Quattro are registered trademarks of Cayenne Medical, Inc.

SureLock and Mirror are trademarks of Cayenne Medical, Inc.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12011146.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
2. DiaTech Life Sciences Announces Medical Advisory Board
3. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
4. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
5. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
6. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
7. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
8. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
9. Live Press Briefing on Findings of Biomedical Industry CEO Survey
10. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
11. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/12/2020)... ... August 11, 2020 , ... ... is making available for free its new white paper – Simulated Transport ... testing into today’s biologics licensing application (BLA). In response, Modality Solutions shares ...
(Date:8/7/2020)... , ... August 06, 2020 , ... ... vaccine industries, announces it has closed on the purchase of greenfield for a ... Conroe, TX and includes over 21 acres in the initial acquisition, with an ...
(Date:8/3/2020)... , ... August 03, 2020 , ... Introducing Ardent Animal ... transformative growth, , Known as MediVet Biologics since its formation ... The new Ardent Animal Health will build on its base of innovative ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON ... of its new tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes ... globe, requiring fast track capacity to provide patients with urgently needed vaccines and ...
Breaking Biology Technology:
(Date:8/21/2020)... ... August 18, 2020 , ... ... today announced that the U.S. Food and Drug Administration (FDA) has approved the ... SBI-101, for the treatment of severe COVID-19. Approval of this IND allows Sentien ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... in Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary ... Both Roche and J&J have annual Research and Development spending in excess of ...
(Date:8/5/2020)... Fla. (PRWEB) , ... August 05, 2020 , ... Regenative ... cover two new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts ... defect using a syringe. The company’s solutions are the first Wharton’s jelly allograft product ...
Breaking Biology News(10 mins):